Is placebo useful in the treatment of major depression in clinical practice?
Carlo Marchesi, Chiara De Panfilis, Matteo Tonna, Paolo Ossola University of Parma, Department of Neuroscience, Psychiatric Unit, Parma, Italy Background: For many years, placebo has been defined by its inert content and use in clinical trials. In recent years, several studies have demonstrated its...
Saved in:
Main Authors: | Marchesi C, De Panfilis C, Tonna M, Ossola P |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/92c7205e6761455cbbaf4950435a73d1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
by: Alvarez E, et al.
Published: (2014) -
Desvenlafaxine in the treatment of major depressive disorder
by: Maria Teresa C Lourenco1, et al.
Published: (2009) -
Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies
by: Han Y, et al.
Published: (2016) -
Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use
by: Singh M, et al.
Published: (2012) -
Transcranial magnetic stimulation for the treatment of major depression
by: Janicak PG, et al.
Published: (2015)